Brazil vs Russia: The number of people with susceptibility test result for rifampicin
Brazil
24,394
in 2021
Russia
21,391
in 2021
Brazil rank
14th
Russia rank
15th
The number of people with susceptibility test result for rifampicin over time
- Brazil
- Russia
How they compare
Brazil currently reports 24,394 against 21,391 in Russia, a difference of 3,003.
That makes Brazil's figure about 1.1 times Russia's.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Russia ahead.
Brazil ranks 14th and Russia ranks 15th of 155 countries.
Across the 2 decades both report, Brazil averaged higher in 1 and Russia in 1.
Head to head by decade
| Decade | Brazil | Russia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 20,251 | 27,743 | 7,493 | Russia |
| 2020s | 24,076 | 21,245 | 2,832 | Brazil |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Brazil or Russia?
- Brazil, at 24,394 against 21,391 in Russia as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Brazil and Russia?
- 3,003, with Brazil ahead.
- How many years of comparable data are there for Brazil and Russia?
- 5 years are reported by both, from 2017 to 2021.
- How do Brazil and Russia rank globally for the number of people with susceptibility test result for rifampicin?
- Brazil ranks 14th and Russia ranks 15th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.